Physician
Fatakia, Adil
Fatakia, Adil was paid $1.15M by Medicaid between Jan 2018 and Apr 2022, across 25 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 29% of everything it billed.
33Billing provider infoFATAKIA, ADIL
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1477737914assigned 12/19/2007
33bProvider typeOtolaryngology Physician
28Total paid$1.15M
24GClaims16,196
24DCodes billed25
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Otolaryngology Physician providers in Louisiana
Rank by total paid#6 of 56
Median peer was paid$82K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,158 | $222K | |
| 2019 | 3,527 | $248K | |
| 2020 | 5,018 | $331K | |
| 2021 | 3,307 | $252K | |
| 2022 | 1,186 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 29% | 1,095 | 831 | $336K |
| 31231 | 15% | 1,592 | 1,519 | $174K | |
| 86003 | 14% | 4,848 | 553 | $156K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.0% | 200 | 175 | $69K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.6% | 1,269 | 1,230 | $64K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 1,895 | 1,700 | $58K |
| 30140 | 4.5% | 204 | 200 | $52K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4.2% | 1,101 | 842 | $48K |
| 31237 | 4.0% | 157 | 134 | $46K | |
| 87581 | 2.7% | 1,098 | 843 | $31K | |
| 87486 | 2.7% | 1,096 | 842 | $31K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 419 | 407 | $28K |
13 more codes
| 70486 | 2.3% | 270 | $26K | |
| 30117 | 1.1% | 52 | $13K | |
| 82785 | <1% | 292 | $4K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 44 | $3K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 15 | $2K |
| 95117 | <1% | 287 | $2K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 14 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $888.40 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $311.40 |
| 36415 | Collection of venous blood by venipuncture | <1% | 130 | $271.56 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 49 | $205.32 |
| 86318 | <1% | 17 | $141.68 | |
| 87631 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.